Contatti
Info
The Janus Pharma Insights is a podcast by Janus Biotech focused on India’s evolving pharmaceutical and healthcare industry. From pharmaceutical manufacturing, PCD pharma franchise, and third-party manufacturing to skincare, nutraceuticals,...
mostra di più
The Janus Pharma Insights is a podcast by Janus Biotech focused on India’s evolving pharmaceutical and healthcare industry. From pharmaceutical manufacturing, PCD pharma franchise, and third-party manufacturing to skincare, nutraceuticals, healthcare innovation, and pharma business growth — this podcast explores the ideas, trends, and strategies shaping the future of the pharma sector.
Each episode brings practical discussions, industry insights, manufacturing knowledge, and healthcare business conversations designed for pharma professionals, distributors, healthcare entrepreneurs, and growing pharmaceutical brands.Powered by Janus Biotech, this podcast shares trusted pharmaceutical industry insights backed by years of experience in India’s healthcare and pharma manufacturing ecosystem.
Explore more at Janus Biotech.
mostra meno
Each episode brings practical discussions, industry insights, manufacturing knowledge, and healthcare business conversations designed for pharma professionals, distributors, healthcare entrepreneurs, and growing pharmaceutical brands.Powered by Janus Biotech, this podcast shares trusted pharmaceutical industry insights backed by years of experience in India’s healthcare and pharma manufacturing ecosystem.
Explore more at Janus Biotech.
Episodi & Post
Episodi
Post
Trascritto
6 OTT 2026 · Episode 14. Nephrology is a high-value, specialist-driven franchise segment — but most distributors don't know what to specifically check before signing with any company. This episode covers the four things that actually matter: dedicated nephrology product range, DCGI approval for nephrology indications, cold chain capability for temperature-sensitive molecules, and division-specific monopoly rights. Full checklist at https://janus.co.in/what-to-check-before-choosing-nephrology-pcd-pharma-company/. Also explore https://janus.co.in/pcd-pharma-franchise/ and https://janus.co.in/third-party-manufacturing/ services. Earlier episodes covered https://www.spreaker.com/episode/how-much-does-it-cost-to-start-a-general-range-pcd-pharma-franchise--73499200, https://www.spreaker.com/episode/gynae-pcd-franchise-why-women-s-healthcare-is-one-of-the-smartest-segments-to-enter-right-now--73497800, https://www.spreaker.com/episode/what-is-biapenem-and-how-does-it-work-against-bacterial-infections--73500500, and https://www.spreaker.com/episode/the-vonoprazan-pcd-opportunity-nobody-s-talking-about-janus-biotech--72851308.
👉 https://janus.co.in/what-to-check-before-choosing-nephrology-pcd-pharma-company/
Trascritto
23 SET 2026 · Episode 13. Biapenem is a carbapenem antibiotic — the class doctors reach for when other antibiotics fail. This episode answers directly: what Biapenem is, how it works by blocking bacterial cell wall synthesis, what infections it treats — septicemia, hospital-acquired pneumonia, complicated UTIs, intra-abdominal infections — and what makes it different from other carbapenems like Meropenem. Full guide at https://janus.co.in/how-does-biapenem-injection-work-against-bacterial-infections/. Also explore https://janus.co.in/product-category/critical-care-range/ and https://janus.co.in/third-party-manufacturing/ services. Earlier episodes covered https://www.spreaker.com/episode/how-much-does-it-cost-to-start-a-general-range-pcd-pharma-franchise--73499200, https://www.spreaker.com/episode/gynae-pcd-franchise-why-women-s-healthcare-is-one-of-the-smartest-segments-to-enter-right-now--73497800, https://www.spreaker.com/episode/why-pharma-brands-choose-janus-biotech-for-contract-manufacturing--73494900, https://www.spreaker.com/episode/the-vonoprazan-pcd-opportunity-nobody-s-talking-about-janus-biotech--72851308, and https://www.spreaker.com/episode/the-rise-of-niacinamide-serum-manufacturing-in-india-podcast--72202452. 👉 https://janus.co.in/how-does-biapenem-injection-work-against-bacterial-infections/
Trascritto
15 SET 2026 · Episode 12. Between ₹60,000 and ₹1,75,000 — that's the realistic investment to start a general range PCD pharma franchise in India in 2026. This episode breaks down exactly where that money goes, what profit margins to expect across antibiotics, antacids, analgesics, and nutraceuticals, what documents you actually need, and how to choose the right franchise partner. Full investment guide at https://janus.co.in/general-range-pcd-pharma-franchise-investment-requirements-profit-potential/. Also explore https://janus.co.in/top-10-gynae-pcd-pharma-companies-in-india/ and https://janus.co.in/pcd-pharma-franchise/. Earlier episodes covered https://www.spreaker.com/episode/gynae-pcd-franchise-why-women-s-healthcare-is-one-of-the-smartest-segments-to-enter-right-now--73497800, https://www.spreaker.com/episode/why-pharma-brands-choose-janus-biotech-for-contract-manufacturing--73494900, https://www.spreaker.com/episode/choosing-a-niacinamide-serum-manufacturer-what-brands-get-wrong--73493800, https://www.spreaker.com/episode/what-s-next-for-vonoprazan-pcd-india-s-gerd-market-through-2027--73275456, https://www.spreaker.com/episode/janus-biotech-one-company-17-divisions-3500-products--73276600, and https://www.spreaker.com/episode/the-rise-of-niacinamide-serum-manufacturing-in-india-podcast--72202452. 👉 https://janus.co.in/general-range-pcd-pharma-franchise-investment-requirements-profit-potential/
Trascritto
3 SET 2026 · Episode 11. PCOS, infertility, prenatal care, menopause management — women's healthcare in India is driven by chronic, long-term conditions that generate consistent repeat prescriptions year-round. This episode covers why the gynae PCD franchise segment is one of the most consistently profitable in Indian pharma, what the full product range looks like, and what to check before signing with any company. Full breakdown of the https://janus.co.in/top-10-gynae-pcd-pharma-companies-in-india/ is in Janus Biotech's 2026 guide. Also explore https://janus.co.in/product-category/gynaecological-range/, https://janus.co.in/pcd-pharma-franchise/, and https://janus.co.in/third-party-manufacturing/ services. Earlier episodes covered https://www.spreaker.com/episode/why-pharma-brands-choose-janus-biotech-for-contract-manufacturing--73494900, https://www.spreaker.com/episode/choosing-a-niacinamide-serum-manufacturer-what-brands-get-wrong--73493800, https://www.spreaker.com/episode/what-s-next-for-vonoprazan-pcd-india-s-gerd-market-through-2027--73275456, https://www.spreaker.com/episode/janus-biotech-one-company-17-divisions-3500-products--73276600, https://www.spreaker.com/episode/the-vonoprazan-pcd-opportunity-nobody-s-talking-about-janus-biotech--72851308, and https://www.spreaker.com/episode/the-rise-of-niacinamide-serum-manufacturing-in-india-podcast--72202452. 👉 https://janus.co.in/top-10-gynae-pcd-pharma-companies-in-india/
Trascritto
27 AGO 2026 · Episode 10. Most pharma brands in India don't own a factory — they partner with a WHO-GMP certified contract manufacturer and focus on building their brand. This episode covers what https://janus.co.in/third-party-manufacturing/ actually offers: a wide product range across tablets, capsules, injectables, syrups, nutraceuticals, and herbal formulations, flexible batch sizes, full DCGI-approved documentation, in-house packaging design, and a transparent process from formulation to final dispatch. Also explore https://janus.co.in/pcd-pharma-franchise/ and https://janus.co.in/product-category/products/. Earlier episodes covered https://www.spreaker.com/episode/choosing-a-niacinamide-serum-manufacturer-what-brands-get-wrong--73493800, https://www.spreaker.com/episode/what-s-next-for-vonoprazan-pcd-india-s-gerd-market-through-2027--73275456, https://www.spreaker.com/episode/janus-biotech-one-company-17-divisions-3500-products--73276600, https://www.spreaker.com/episode/is-vonoprazan-pcd-the-right-franchise-for-you-janus-biotech--72853089, https://www.spreaker.com/episode/vonoprazan-hp-kit-and-domperidone-the-gastro-combinations-worth-knowing-janus-biotech--72852263, https://www.spreaker.com/episode/the-vonoprazan-pcd-opportunity-nobody-s-talking-about-janus-biotech--72851308, https://www.spreaker.com/episode/vonoprazan-the-next-gen-acid-reflux-treatment-janus-biotech--72700491, and https://www.spreaker.com/episode/the-rise-of-niacinamide-serum-manufacturing-in-india-podcast--72202452. 👉 https://janus.co.in/third-party-manufacturing/
Trascritto
20 AGO 2026 · Episode 9. Most skincare brands choose a niacinamide serum manufacturer based on price — and most of them regret it. This episode covers what actually matters when evaluating a supplier: formulation expertise, certifications, stability testing standards, MOQ flexibility, and communication. Based on https://janus.co.in/how-to-choose-the-best-niacinamide-serum-supplier/ — covering everything from R&D capability and GMP compliance to private label and custom formulation services. Also explore https://janus.co.in/niacinamide-serum-manufacturers/ and https://janus.co.in/third-party-manufacturing/. Earlier episodes covered https://www.spreaker.com/episode/what-s-next-for-vonoprazan-pcd-india-s-gerd-market-through-2027--73275456, https://www.spreaker.com/episode/janus-biotech-one-company-17-divisions-3500-products--73276600, https://www.spreaker.com/episode/is-vonoprazan-pcd-the-right-franchise-for-you-janus-biotech--72853089, https://www.spreaker.com/episode/vonoprazan-hp-kit-and-domperidone-the-gastro-combinations-worth-knowing-janus-biotech--72852263, https://www.spreaker.com/episode/the-vonoprazan-pcd-opportunity-nobody-s-talking-about-janus-biotech--72851308, https://www.spreaker.com/episode/vonoprazan-the-next-gen-acid-reflux-treatment-janus-biotech--72700491, and https://www.spreaker.com/episode/the-rise-of-niacinamide-serum-manufacturing-in-india-podcast--72202452. 👉 https://janus.co.in/how-to-choose-the-best-niacinamide-serum-supplier/
Trascritto
12 AGO 2026 · Episode 8. India's GERD market is projected to reach ₹2,245 crore by 2033, and Vonoprazan is capturing a growing share of it — backed by Torrent, Lupin, Dr Reddy's, Zydus, and Mankind all launching their own brands. This episode covers the https://janus.co.in/future-of-vonoprazan-pcd-pharma-business-in-india/ through 2027 — falling prices, growing combination products, and why tier-2 and tier-3 cities are where the real opportunity lies for franchise partners right now. Also explore https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/ and the https://janus.co.in/product/vonoprazan-20-mg-10mg/. Earlier episodes covered https://www.spreaker.com/episode/janus-biotech-one-company-17-divisions-3500-products--73276600, https://www.spreaker.com/episode/is-vonoprazan-pcd-the-right-franchise-for-you-janus-biotech--72853089, https://www.spreaker.com/episode/vonoprazan-hp-kit-and-domperidone-the-gastro-combinations-worth-knowing-janus-biotech--72852263, https://www.spreaker.com/episode/the-vonoprazan-pcd-opportunity-nobody-s-talking-about-janus-biotech--72851308, https://www.spreaker.com/episode/vonoprazan-the-next-gen-acid-reflux-treatment-janus-biotech--72700491, and https://www.spreaker.com/episode/the-rise-of-niacinamide-serum-manufacturing-in-india-podcast--72202452. 👉 https://janus.co.in/future-of-vonoprazan-pcd-pharma-business-in-india/
Trascritto
5 AGO 2026 · Episode 7. Six episodes in and we've been deep in Vonoprazan — today we step back and look at https://janus.co.in/ as a whole. From a single pharmacy in 1957 to one of North India's fastest growing pharma companies, with 3500+ products, 1500+ business partners, and 17 specialized divisions covering gastro, cardiac, gynecology, derma, pediatrics, nutraceuticals, orthopedics and more. This episode covers what that range means for franchise partners and why a multi-division company changes the math on long-term business growth. Explore https://janus.co.in/pcd-pharma-franchise/, https://janus.co.in/third-party-manufacturing/, and the https://janus.co.in/product-category/products/ at Janus Biotech. Earlier episodes covered https://www.spreaker.com/episode/vonoprazan-the-next-gen-acid-reflux-treatment-janus-biotech--72700491, https://www.spreaker.com/episode/the-vonoprazan-pcd-opportunity-nobody-s-talking-about-janus-biotech--72851308, https://www.spreaker.com/episode/vonoprazan-hp-kit-and-domperidone-the-gastro-combinations-worth-knowing-janus-biotech--72852263, https://www.spreaker.com/episode/is-vonoprazan-pcd-the-right-franchise-for-you-janus-biotech--72853089, and https://www.spreaker.com/episode/what-s-next-for-vonoprazan-pcd-india-s-gerd-market-through-2027--73275456.
👉 https://janus.co.in/
Trascritto
31 LUG 2026 · Vonoprazan is reshaping how India treats acid reflux, working faster and controlling night-time acid breakthrough better than older PPIs like pantoprazole or omeprazole — which is why major players from Torrent to Mankind have launched their own versions within months of each other. In this episode, we look at where the Vonoprazan PCD opportunity is headed through 2027, from falling prices as exclusivity fades to the rise of H. pylori combination products, and why tier 2 and tier 3 cities are set to drive most of the growth. This continues what we've built up in earlier episodes — starting with https://www.spreaker.com/cms/shows/6988873/EP1_URL, then https://www.spreaker.com/cms/shows/6988873/EP2_URL, https://www.spreaker.com/cms/shows/6988873/EP3_URL, and https://www.spreaker.com/cms/shows/6988873/EP4_URL. For the full market breakdown behind this episode, read https://janus.co.in/future-of-vonoprazan-pcd-pharma-business-in-india/.
Trascritto
24 LUG 2026 · Episode 5. Vonoprazan PCD franchise is gaining traction — but is it the right move for your business? This episode breaks down the honest case: chronic repeat prescriptions, early mover advantage in a growing category, and a versatile product range covering GERD, nausea, and H. pylori eradication. Full details in https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/. If you're just joining us, Episode 2 covered https://www.spreaker.com/episode/vonoprazan-the-next-gen-acid-reflux-treatment-janus-biotech--72700491, Episode 3 broke down https://www.spreaker.com/episode/the-vonoprazan-pcd-opportunity-nobody-s-talking-about-janus-biotech--72851308, and Episode 4 explored https://www.spreaker.com/episode/vonoprazan-hp-kit-and-domperidone-the-gastro-combinations-worth-knowing-janus-biotech--72852263. Episode 1 covered https://www.spreaker.com/episode/the-rise-of-niacinamide-serum-manufacturing-in-india-podcast--72202452. https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/
The Janus Pharma Insights is a podcast by Janus Biotech focused on India’s evolving pharmaceutical and healthcare industry. From pharmaceutical manufacturing, PCD pharma franchise, and third-party manufacturing to skincare, nutraceuticals,...
mostra di più
The Janus Pharma Insights is a podcast by Janus Biotech focused on India’s evolving pharmaceutical and healthcare industry. From pharmaceutical manufacturing, PCD pharma franchise, and third-party manufacturing to skincare, nutraceuticals, healthcare innovation, and pharma business growth — this podcast explores the ideas, trends, and strategies shaping the future of the pharma sector.
Each episode brings practical discussions, industry insights, manufacturing knowledge, and healthcare business conversations designed for pharma professionals, distributors, healthcare entrepreneurs, and growing pharmaceutical brands.Powered by Janus Biotech, this podcast shares trusted pharmaceutical industry insights backed by years of experience in India’s healthcare and pharma manufacturing ecosystem.
Explore more at Janus Biotech.
mostra meno
Each episode brings practical discussions, industry insights, manufacturing knowledge, and healthcare business conversations designed for pharma professionals, distributors, healthcare entrepreneurs, and growing pharmaceutical brands.Powered by Janus Biotech, this podcast shares trusted pharmaceutical industry insights backed by years of experience in India’s healthcare and pharma manufacturing ecosystem.
Explore more at Janus Biotech.
Informazioni
| Autore | Janus Biotech |
| Organizzazione | janus |
| Categorie | Alimentazione , Gastronomia , Salute e benessere |
| Sito | janus.co.in |
| janusbiotech12@gmail.com |
Copyright 2026 - Spreaker Inc. an iHeartMedia Company
